Jerry Williamson
President
Business and Developement
KEW Group
United States of America
Biography
Jerry Williamson brings more than 30 years of commercial operating, business development and corporate management experience in the diagnostic and life science marketplace where he has held executive leadership roles responsible for value creation, growth and profitability. Most recently, Jerry was President and CEO of Metamark Genetics, Inc., a private molecular diagnostics company, which he joined in 2015. Prior to Metamark, Jerry was a Partner with Flagship Ventures focused on building and developing relationships with corporate partners for the firm’s core innovation and investment activities. He was President of Global Commercial Operations for Genetix Ltd., a UK-based bioresearch imaging company that was sold to Danaher and merged with Molecular Devices where Jerry served as Vice President and General Manager. As President of Biacore, Inc., Jerry ran the North American subsidiary of this European biotech instrument supplier, where he was also responsible for post-acquisition integration into GE Healthcare. Jerry was also President of Pyrosequencing, Inc., the US subsidiary of a Swedish-led DNA sequencing platform provider. Jerry received a BS degree in Biochemistry from the University of Vermont and holds an MBA degree from Boston University.
Research Interest
Business Management
